Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Giant Cell Tumor of Bone

fluorodeoxyglucose f18 has been researched along with Giant Cell Tumor of Bone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's8 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, N; Hirozane, T; Matsumoto, M; Morioka, H; Nakamura, M; Nakayama, R; Nishimoto, K; Okita, H; Otani, S; Sasaki, A; Sekita, T1
Basques, K; Behzadi, AH; Carrino, JA; Gholamrezanezhad, A; Jadvar, H; Kosmas, C; Matcuk, GR; Patel, J; Raza, SI1
Kairemo, K; Subbiah, V; Wang, WL1
Fernandez, M; Garcia, RA; Maya, S; Noor, A; Pawha, PS; Pina, S; Som, PM1
Hakozaki, M; Hasegawa, O; Konno, S; Tajino, T; Tasaki, K; Watanabe, K; Yamada, H1
Ishidou, Y; Komiya, S; Nagano, S; Nakamura, S; Sasaki, H; Setoguchi, T; Shimada, H; Tsuchimochi, T; Yamamoto, T; Yokouchi, M1
Goffin, E; Hermoye, A; Lecouvet, F; Lhommel, R; Lonneux, M; Malghem, J1
Hickeson, M; Makis, W1
Hata, K; Hoshi, M; Ieguchi, M; Nakamura, H; Oebisu, N; Takada, J1
Arens, A; de Jong, J; Kremer, B; Lambin, P; Thimister, P; van Baardwijk, A; Verseput, G1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Giant Cell Tumor of Bone

ArticleYear
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
    PET clinics, 2018, Volume: 13, Issue:4

    Topics: Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult

2018

Other Studies

9 other study(ies) available for fluorodeoxyglucose f18 and Giant Cell Tumor of Bone

ArticleYear
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report.
    BMC cancer, 2019, Sep-03, Volume: 19, Issue:1

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hemangioendothelioma, Epithelioid; Humans; Treatment Outcome; Young Adult

2019
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
    BMJ case reports, 2019, Apr-23, Volume: 12, Issue:4

    Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed

2019
Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia: the use of imaging to assess recurrence.
    The neuroradiology journal, 2014, Volume: 27, Issue:1

    Topics: Cartilage; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Metaplasia; Middle Aged; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Skull Neoplasms; Temporal Bone; Temporomandibular Joint Disorders; Tinnitus; Tomography, X-Ray Computed

2014
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.
    Diagnostic pathology, 2014, Jun-07, Volume: 9

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Denosumab; Femoral Neoplasms; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteotomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tibia; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2014
Giant cell tumor of the clavicle: report of a case in a rare location with consideration of surgical method.
    BMC musculoskeletal disorders, 2015, Jun-12, Volume: 16

    Topics: Biomechanical Phenomena; Biopsy; Bone Neoplasms; Clavicle; Contrast Media; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteotomy; Positron-Emission Tomography; Range of Motion, Articular; Tomography, X-Ray Computed; Treatment Outcome

2015
F-18 FDG PET/CT as a noninvasive diagnostic and follow-up tool in brown tumors due to secondary hyperparathyroidism.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:5

    Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Tumor of Bone; Humans; Hyperparathyroidism, Secondary; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2009
Spindle cell sarcoma degeneration of giant cell tumor of the knee, imaged with F-18 FDG PET-CT and Tc-99m MDP bone scan.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:2

    Topics: Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Knee; Male; Middle Aged; Positron-Emission Tomography; Sarcoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed

2010
Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
    Archives of orthopaedic and trauma surgery, 2012, Volume: 132, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Hexokinase; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult

2012
False-positive FDG-PET scan due to brown tumours.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:3

    Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Laryngeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2006